Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis

PHASE4CompletedINTERVENTIONAL
Enrollment

2,571

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

August 31, 2021

Conditions
Myocardial InfarctionInfluenza, HumanInfluenza VaccinesHeart FailureStroke
Interventions
BIOLOGICAL

Influenza vaccine

BIOLOGICAL

Placebo

Trial Locations (29)

Unknown

Blacktown Hospital, Sydney

National Heart Foundation and Research Institute (NHFH), Dhaka

National Institute of Cardiovascular Diseases (NICVD), Dhaka

St. Anne University Hospital, Brno

University Hospital Kralovske Vinohrady, Prague

Aalborg University Hospital, Aalborg

Aarhus University Hospital, Aarhus

Bispebjerg Hospital, Copenhagen

Rigshospitalet, University of Copenhagen, Copenhagen

Odense University Hospital, Odense

Pauls Stradins Clinical University Hospital, Riga

LHL-sykehuset Gardermoen, Oslo

Sahlgrenska sjukhuset, Gothenburg

Jönköping Hospital, Jönköping

Karlstad Central Hospital, Karlstad

University Hospital Linkoping, Linköping

Skånes universitetssjukhus, Lund

Danderyds sjukhus, Stockholm

Karolinska University Hospital, Stockholm

Stockholm South General Hospital, Stockholm

University Hospital Umeå, Umeå

Uppsala University Hospital, Uppsala

Centrallasarettet, Västerås

Victoria Hospital, Kirkcaldy

Aberdeen Royal Infirmary, Aberdeen

Ninewells Hospital, Dundee

Royal Infirmary of Edinburg, Edinburgh

Golden Jubilee National Hospital, Glasgow

Hairmyres Hospital, Glasgow

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Swedish Heart Lung Foundation

OTHER

collaborator

Sanofi Pasteur, a Sanofi Company

INDUSTRY

collaborator

Uppsala University

OTHER

collaborator

Lytics

UNKNOWN

lead

Ole Frobert, MD, PhD

OTHER